Indivior

Indivior is a global pharmaceutical company working to help change patients’ lives by pioneering lifetransforming treatment for addiction and other serious mental illnesses. Indivior manufactures and markets medicines for the treatment of moderate to severe opioid use disorder with a global portfolio in over 40 countries. Indivior also markets medicine for the treatment of schizophrenia in adults in the United States and has a licensing agreement to bring this treatment to patients suffering from schizophrenia in Canada. We continue to be an essential company helping in the fight against the opioid epidemic. Indivior remains committed to discovering and developing new and effective treatments to help patients struggling with this disease. Medication for opioid use disorder (MOUD) is increasingly recognized as an important part of addressing the opioid crisis. The medications Indivior provides play an essential role in treating opioid use disorder and addressing the opioid crisis. Working with others, we are driving forward our understanding of addiction and other serious mental health diseases, working to create new science to help pave the way for an even deeper understanding of patient needs and treatment innovation

Webinar: Opioid Use Disorder- A Chronic, Treatable Brain Disease (10/17/23)

• View the Full Recording